by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Silgan Dispensing Systems Warning Letter Details

Warning Letter

Silgan Dispensing Systems

1001 Haxall Point, Suite 701 Richmond , VA 23219 United States, (b)(4)

Issue DateOctober 05, 2026

FEI Number3011913386

Violations4

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug

Silgan Dispensing Systems FDA Warning Letter, October 5, 2026